Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SVRA · against 470 other Healthcare companies of similar size
Ranked #429 of 471 · scores higher than 8% of peers
Bars: peers in each 10-point band of the profitability score51 peers with a profitability score of 10–19, including SVRA · Click a bar to see the companies
Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | SVRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 449 reported | -86.0% | 4.5% | 8% | 33% | |
| Operating marginHigher is better · 442 reported | Not reported | 6.6% | — | — | 33% |
| Return on assetsHigher is better · 458 reported | -72.5% | 1.5% | 3% | 33% | |
| Return on equityHigher is better · 440 reported | -105.5% | 2.8% | 7% | Context only | |
| Gross marginHigher is better · 490 reported | 0.0% | 46.0% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 2 | 578M USD | 99 | 73 | |
| 429 | 660M USD | 11 | 43 | |
| 429 | 552M USD | 11 | 39 | |
| 429 | 1.3B USD | 11 | 39 | |
| 429 | 1.2B USD | 11 | 40 | |
| 429 | 976M USD | 11 | 36 | |
| 435 | 504M USD | 10 | 24 | |
| 435 | 588M USD | 10 | 24 | |
| 437 | 9.9B HKD (≈$1.3B) | 9 | 17 | |
| 437 | 1.3B USD | 9 | 15 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score